The Beauty Health Company (SKIN) Stock Competitors & Peer Comparison
See (SKIN) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SKIN | $0.63 | +4.36% | 82.2M | -4.88 | -$0.13 | N/A |
| PG | $145.10 | -0.98% | 337.9B | 21.21 | $6.84 | +2.92% |
| UL | $56.09 | -1.11% | 121.5B | 18.64 | $3.01 | +4.06% |
| CL | $86.07 | -2.83% | 68.9B | 33.35 | $2.58 | +2.42% |
| KVUE | $17.55 | -0.90% | 33.7B | 20.90 | $0.84 | +4.69% |
| KMB | $97.75 | -1.30% | 32.4B | 18.91 | $5.17 | +5.15% |
| EL | $84.64 | +1.38% | 30.6B | -120.84 | -$0.70 | +1.66% |
| CHD | $95.35 | -1.44% | 22.6B | 31.37 | $3.04 | +1.26% |
| SGI | $67.81 | -0.29% | 14.3B | 27.14 | $2.50 | +0.94% |
| CLX | $95.16 | +1.08% | 11.5B | 15.47 | $6.15 | +5.17% |
Stock Comparison
SKIN vs PG Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, PG has a market cap of 337.9B. Regarding current trading prices, SKIN is priced at $0.63, while PG trades at $145.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas PG's P/E ratio is 21.21. In terms of profitability, SKIN's ROE is -0.09%, compared to PG's ROE of +0.31%. Regarding short-term risk, SKIN is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PG's competition here
SKIN vs UL Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, UL has a market cap of 121.5B. Regarding current trading prices, SKIN is priced at $0.63, while UL trades at $56.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas UL's P/E ratio is 18.64. In terms of profitability, SKIN's ROE is -0.09%, compared to UL's ROE of +0.36%. Regarding short-term risk, SKIN is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UL's competition here
SKIN vs CL Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, CL has a market cap of 68.9B. Regarding current trading prices, SKIN is priced at $0.63, while CL trades at $86.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas CL's P/E ratio is 33.35. In terms of profitability, SKIN's ROE is -0.09%, compared to CL's ROE of +4.75%. Regarding short-term risk, SKIN is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CL's competition here
SKIN vs KVUE Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, KVUE has a market cap of 33.7B. Regarding current trading prices, SKIN is priced at $0.63, while KVUE trades at $17.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas KVUE's P/E ratio is 20.90. In terms of profitability, SKIN's ROE is -0.09%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, SKIN is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check KVUE's competition here
SKIN vs KMB Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, KMB has a market cap of 32.4B. Regarding current trading prices, SKIN is priced at $0.63, while KMB trades at $97.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas KMB's P/E ratio is 18.91. In terms of profitability, SKIN's ROE is -0.09%, compared to KMB's ROE of +1.44%. Regarding short-term risk, SKIN is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check KMB's competition here
SKIN vs EL Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, EL has a market cap of 30.6B. Regarding current trading prices, SKIN is priced at $0.63, while EL trades at $84.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas EL's P/E ratio is -120.84. In terms of profitability, SKIN's ROE is -0.09%, compared to EL's ROE of -0.06%. Regarding short-term risk, SKIN is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EL's competition here
SKIN vs CHD Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, CHD has a market cap of 22.6B. Regarding current trading prices, SKIN is priced at $0.63, while CHD trades at $95.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas CHD's P/E ratio is 31.37. In terms of profitability, SKIN's ROE is -0.09%, compared to CHD's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CHD's competition here
SKIN vs SGI Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, SGI has a market cap of 14.3B. Regarding current trading prices, SKIN is priced at $0.63, while SGI trades at $67.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas SGI's P/E ratio is 27.14. In terms of profitability, SKIN's ROE is -0.09%, compared to SGI's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SGI's competition here
SKIN vs CLX Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, CLX has a market cap of 11.5B. Regarding current trading prices, SKIN is priced at $0.63, while CLX trades at $95.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas CLX's P/E ratio is 15.47. In terms of profitability, SKIN's ROE is -0.09%, compared to CLX's ROE of +28.26%. Regarding short-term risk, SKIN is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check CLX's competition here
SKIN vs NTCO Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, SKIN is priced at $0.63, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas NTCO's P/E ratio is -11.37. In terms of profitability, SKIN's ROE is -0.09%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, SKIN is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NTCO's competition here
SKIN vs ELF Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, ELF has a market cap of 3.1B. Regarding current trading prices, SKIN is priced at $0.63, while ELF trades at $52.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas ELF's P/E ratio is 118.83. In terms of profitability, SKIN's ROE is -0.09%, compared to ELF's ROE of +0.05%. Regarding short-term risk, SKIN is more volatile compared to ELF. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check ELF's competition here
SKIN vs IPAR Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, IPAR has a market cap of 3B. Regarding current trading prices, SKIN is priced at $0.63, while IPAR trades at $92.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas IPAR's P/E ratio is 17.53. In terms of profitability, SKIN's ROE is -0.09%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, SKIN is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check IPAR's competition here
SKIN vs SPB Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, SKIN is priced at $0.63, while SPB trades at $81.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas SPB's P/E ratio is 15.90. In terms of profitability, SKIN's ROE is -0.09%, compared to SPB's ROE of +0.07%. Regarding short-term risk, SKIN is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SPB's competition here
SKIN vs NWL Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, NWL has a market cap of 1.8B. Regarding current trading prices, SKIN is priced at $0.63, while NWL trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas NWL's P/E ratio is -6.28. In terms of profitability, SKIN's ROE is -0.09%, compared to NWL's ROE of -0.11%. Regarding short-term risk, SKIN is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check NWL's competition here
SKIN vs COTY Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, COTY has a market cap of 1.7B. Regarding current trading prices, SKIN is priced at $0.63, while COTY trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas COTY's P/E ratio is -3.12. In terms of profitability, SKIN's ROE is -0.09%, compared to COTY's ROE of -0.15%. Regarding short-term risk, SKIN is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check COTY's competition here
SKIN vs EPC Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, EPC has a market cap of 935.2M. Regarding current trading prices, SKIN is priced at $0.63, while EPC trades at $20.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas EPC's P/E ratio is -88.24. In terms of profitability, SKIN's ROE is -0.09%, compared to EPC's ROE of -0.05%. Regarding short-term risk, SKIN is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EPC's competition here
SKIN vs HELE Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, HELE has a market cap of 587.5M. Regarding current trading prices, SKIN is priced at $0.63, while HELE trades at $25.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas HELE's P/E ratio is -0.65. In terms of profitability, SKIN's ROE is -0.09%, compared to HELE's ROE of -0.95%. Regarding short-term risk, SKIN is more volatile compared to HELE. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check HELE's competition here
SKIN vs EWCZ Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, SKIN is priced at $0.63, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, SKIN's ROE is -0.09%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, SKIN is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check EWCZ's competition here
SKIN vs NUS Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, NUS has a market cap of 258.3M. Regarding current trading prices, SKIN is priced at $0.63, while NUS trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas NUS's P/E ratio is 4.93. In terms of profitability, SKIN's ROE is -0.09%, compared to NUS's ROE of +0.07%. Regarding short-term risk, SKIN is more volatile compared to NUS. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check NUS's competition here
SKIN vs PTNM Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, SKIN is priced at $0.63, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas PTNM's P/E ratio is 346.33. In terms of profitability, SKIN's ROE is -0.09%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, SKIN is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check PTNM's competition here
SKIN vs ACU Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, ACU has a market cap of 165.3M. Regarding current trading prices, SKIN is priced at $0.63, while ACU trades at $43.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas ACU's P/E ratio is 18.70. In terms of profitability, SKIN's ROE is -0.09%, compared to ACU's ROE of +0.08%. Regarding short-term risk, SKIN is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check ACU's competition here
SKIN vs SLSN Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, SLSN has a market cap of 84.8M. Regarding current trading prices, SKIN is priced at $0.63, while SLSN trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas SLSN's P/E ratio is 120.00. In terms of profitability, SKIN's ROE is -0.09%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, SKIN is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check SLSN's competition here
SKIN vs GROV Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, GROV has a market cap of 50.9M. Regarding current trading prices, SKIN is priced at $0.63, while GROV trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas GROV's P/E ratio is -4.48. In terms of profitability, SKIN's ROE is -0.09%, compared to GROV's ROE of -1.06%. Regarding short-term risk, SKIN is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check GROV's competition here
SKIN vs AXIL Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, AXIL has a market cap of 45.7M. Regarding current trading prices, SKIN is priced at $0.63, while AXIL trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas AXIL's P/E ratio is 55.92. In terms of profitability, SKIN's ROE is -0.09%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, SKIN is more volatile compared to AXIL. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check AXIL's competition here
SKIN vs UG Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, UG has a market cap of 31.7M. Regarding current trading prices, SKIN is priced at $0.63, while UG trades at $6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas UG's P/E ratio is 13.29. In terms of profitability, SKIN's ROE is -0.09%, compared to UG's ROE of +0.21%. Regarding short-term risk, SKIN is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check UG's competition here
SKIN vs MTEX Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, MTEX has a market cap of 10.9M. Regarding current trading prices, SKIN is priced at $0.63, while MTEX trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas MTEX's P/E ratio is -0.84. In terms of profitability, SKIN's ROE is -0.09%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, SKIN is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check MTEX's competition here
SKIN vs PHH Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, SKIN is priced at $0.63, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas PHH's P/E ratio is -0.53. In terms of profitability, SKIN's ROE is -0.09%, compared to PHH's ROE of +0.38%. Regarding short-term risk, SKIN is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check PHH's competition here
SKIN vs RAY Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, RAY has a market cap of 9.6M. Regarding current trading prices, SKIN is priced at $0.63, while RAY trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas RAY's P/E ratio is 4.36. In terms of profitability, SKIN's ROE is -0.09%, compared to RAY's ROE of +0.09%. Regarding short-term risk, SKIN is more volatile compared to RAY. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check RAY's competition here
SKIN vs BRSH Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, SKIN is priced at $0.63, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas BRSH's P/E ratio is -0.01. In terms of profitability, SKIN's ROE is -0.09%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, SKIN is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BRSH's competition here
SKIN vs DSY Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, DSY has a market cap of 8.4M. Regarding current trading prices, SKIN is priced at $0.63, while DSY trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas DSY's P/E ratio is -0.20. In terms of profitability, SKIN's ROE is -0.09%, compared to DSY's ROE of +14.77%. Regarding short-term risk, SKIN is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check DSY's competition here
SKIN vs TANH Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, TANH has a market cap of 3.1M. Regarding current trading prices, SKIN is priced at $0.63, while TANH trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas TANH's P/E ratio is -0.04. In terms of profitability, SKIN's ROE is -0.09%, compared to TANH's ROE of -0.25%. Regarding short-term risk, SKIN is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check TANH's competition here
SKIN vs TKLF Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, TKLF has a market cap of 842.3K. Regarding current trading prices, SKIN is priced at $0.63, while TKLF trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas TKLF's P/E ratio is 1.81. In terms of profitability, SKIN's ROE is -0.09%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, SKIN is more volatile compared to TKLF. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check TKLF's competition here
SKIN vs DSYWW Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, DSYWW has a market cap of 814K. Regarding current trading prices, SKIN is priced at $0.63, while DSYWW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas DSYWW's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, SKIN is more volatile compared to DSYWW. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check DSYWW's competition here
SKIN vs BRSHW Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, SKIN is priced at $0.63, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas BRSHW's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, SKIN is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for SKIN.Check BRSHW's competition here
SKIN vs SUMR Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.63, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas SUMR's P/E ratio is -3.66. In terms of profitability, SKIN's ROE is -0.09%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, SKIN is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check SUMR's competition here
SKIN vs RDEN Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.63, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas RDEN's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, SKIN is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check RDEN's competition here
SKIN vs GROV-WT Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.63, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.09%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, SKIN is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check GROV-WT's competition here
SKIN vs REV Comparison June 2026
SKIN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 82.2M. In comparison, REV has a market cap of 0. Regarding current trading prices, SKIN is priced at $0.63, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -4.88, whereas REV's P/E ratio is -1.19. In terms of profitability, SKIN's ROE is -0.09%, compared to REV's ROE of +0.89%. Regarding short-term risk, SKIN is more volatile compared to REV. This indicates potentially higher risk in terms of short-term price fluctuations for SKIN.Check REV's competition here